This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2014)
- Jupiter, FL (US) (2017)
Company Filing History:
Years Active: 2014-2017
Title: Innovations in Cancer Treatment by Brian D Jones
Introduction
Brian D Jones is an accomplished inventor based in Jupiter, FL (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. With a total of 2 patents, his work focuses on the creation of anticancer agents that aim to improve therapeutic outcomes for patients.
Latest Patents
One of Brian's latest patents involves the development of anti-cancer polyketide compounds. These compounds are designed to treat cancer by regulating the spliceosome and detecting spliceosome inhibition. Another notable patent relates to anticancer agents, which includes compositions and methods for treating cancer using novel spirohexenolides. These advancements highlight his commitment to finding effective solutions for cancer treatment.
Career Highlights
Brian D Jones is affiliated with the University of California, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science. His innovative approach to drug development has positioned him as a key figure in the fight against cancer.
Collaborations
Brian collaborates with esteemed colleagues such as Michael D Burkart and James J La Clair. Their combined expertise enhances the research efforts and contributes to the development of groundbreaking cancer treatments.
Conclusion
In summary, Brian D Jones is a notable inventor whose work in cancer treatment through innovative compounds is paving the way for new therapeutic options. His contributions to the field are significant and reflect a deep commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
